Back
Larimar Therapeutics 10K Form
Sell
41
LRMR
Larimar Therapeutics
Last Price:
6.76
Seasonality Move:
-3.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LRMR News And Ratings
See the #1 stock for the next 7 days that we like better than LRMR
LRMR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-14.26M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.31 |
| Price / Book: | 2.17 |
Profitability
| EPS (TTM): | -1.11000 |
|---|---|
| Net Income (TTM): | $-58.34M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Larimar Therapeutics Earnings Forecast
Key Larimar Therapeutics Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 3 years.
Larimar Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LRMR |
| CUSIP: | 517125 |
| Website: | larimartx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LRMR Technical Analysis vs Fundamental Analysis
Sell
41
Larimar Therapeutics (LRMR)
is a Sell
Is Larimar Therapeutics a Buy or a Sell?
-
Larimar Therapeutics stock is rated a Sell
The current Larimar Therapeutics [LRMR] share price is $7.20. The Score for LRMR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.